Two teams independently come up with a way to avert CRS in CAR T-cell therapies

Two teams of researchers, one working in the U.S., the other in Italy, have come up with new ways to avert cytokine release syndrome (CRS) in leukemia patients who undergo CAR T-cell therapies.